Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2021, 819 Capital Partners is a venture capital firm based in the Netherlands. The firm specializes in venture capital, private equity, and corporate finance, managing a portfolio of 9 companies. Their investment strategy spans multiple stages, including pre-seed, seed, and Series B.
819 Capital Partners invests in sectors such as healthcare, technology, and leisure, with a particular emphasis on deep-tech ventures. Their strategy includes funding early-stage to established companies, utilizing the 819 Evergreen Fund to support innovations that tackle societal challenges.
Notable portfolio companies include ScoutinScience, an AI platform for identifying high-potential scientific literature; Powall, which enhances battery performance using nanotechnology; and I-Med Technology, known for advanced 3D imaging systems for medical procedures. Other companies include AIKON Health, developing wearable biosensors for heart-failure management, and Viruma, specializing in roofing and façade systems.
Email your pitch deck to info@819-capital.com.
As of October 2023, 819 Capital Partners has been active in acquiring stakes in companies such as Lead Pharma and Chalet.nl, as well as a significant minority stake in RiverD, indicating their commitment to expanding their portfolio.
They invest across multiple stages, including pre-seed, seed, seed-plus, Series A, and Series B.
The firm focuses on healthcare, technology, and leisure, with a strong emphasis on deep-tech ventures.
Interested founders can email their pitch deck to info@819-capital.com.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.